The following are some interesting topics and posts from the last week or so. A lot of links, but they're pretty good.
Online education (i.e. MOOCs)
- At the Chronicle of Higher Education, George Washington University Dean Doug Guthrie criticizes Coursera, a for-profit company that partners with universities to offer massive online open courses (MOOCs). Guthrie insists that Coursera is a fad; "thoughtful interactions" do not occur; and educators are frequently creating a crowd, not a community. It's a valid point; online education has promise but very often falls short, even with the best of intentions. See also this other criticism/analysis of MOOCs. While we're at it, if you really want to read more about MOOCs check out this year-in-review about MOOCs.
- In the midst of the recent surge in MOOC popularity, the University of Illinois at Urbana-Champaign is running an online Intermediate Organic Chemistry course, taught by educational specialist Michael Evans and Dr. Jeff Moore.
- Dayna Catropa and Margaret Andrews compare MOOCs to MOCCs (midsized online closed courses), predicting that MOCCs will replace MOOCs, as they provide an opportunity to monetize the online experience and deliver it to smaller groups.
Public health
- Antibiotic resistance is a serious public health concern, but a potential new class of antibiotics that take advantage of the dependence of certain pathogens on the thioredoxin system is displaying promise against MRSA, drug-resistant TB, etc. Malaria is also notoriously drug-resistant, and this press release details a surprisingly simple whole-plant antimalarial strategy that may be effective and cost-effecient. This stands in contrast to the widespread practice of synthetic, pure drugs.
- While we're on the subject of antibiotics, Katherine Harmon at ScientificAmerican writes on recent findings that amoxicillin is not only overprescribed but is ineffective compared to a placebo for most of its common applications. Add another one to the "no, seriously, stop giving out antibiotics like candy" file.
- Antibiotic use in agriculture is controversial, and Maryn McKenna at WiredScience writes on the FDA's reluctance to compel companies to disclose farm antibiotic use. On a related note, The Pump Handle criticizes a recent USDA decision to "modernize" poultry inspection; the author says that the new guidelines, which aim to speed up the inspection process, would threaten food safety.
- Personalized medicine has gotten a lot of recent attention as a strategy for fighting disease (particularly cancer). The general strategy is to target therapeutics based on a patient's genome. However, personalized medicine has its skeptics, and a commentary by Sharon Begley examines recent evidence that this approach may never be effective.
Scientific communication
- At the Chronicle of Higher Education, Indiana University president Michael A. McRobbie warns that the fiscal cliff may spell out serious damage to research universities. He makes the case that this would be perilous to the economy, as research drives innovation in engineering/manufacturing.
- The United States is not the only place where scientists are feeling the squeeze of a scant funding environment. Nature gives an account of Spanish scientists who protested their government's reductions in science funding (39% drop since 2009).
Scientific philosophy
- On HuffingtonPost, Dr. Rupert Sheldrake writes a commentary on the arrogance of modern science, criticizing materialism and insisting that dogmatic thinking is "crippling" modern science. I disagree with most of what he says; it's overly dramatic, simplistic, and feels like it's pandering to the pseudoscientist crowd (as well as an advertisement for the author's new book). But it's worth reading; is this a pervasive viewpoint?
- For the philosophically inclined, read this. (tl;dr = is science tool-driven or idea-driven??).
Other